Comparison of nonhuman primate antibodies against Haemophilus influenzae type b polysaccharide with human antibodies in oligoclonality and in vivo protective potency

Nonhuman primates are often used as a model for studying vaccines for humans. However, it is not always clear how closely the antibody responses in these species mimic human responses. Recent studies have characterized the human antibody response to Haemophilus influenzae type b (Hib) in great detai...

Full description

Saved in:
Bibliographic Details
Published inInfection and Immunity Vol. 62; no. 6; pp. 2426 - 2431
Main Authors Kim, K.H, Park, M.K, Peeters, C.C, Poolman, J.T, Shearer, M.H, Kennedy, R.C, Nahm, M.H
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.06.1994
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Nonhuman primates are often used as a model for studying vaccines for humans. However, it is not always clear how closely the antibody responses in these species mimic human responses. Recent studies have characterized the human antibody response to Haemophilus influenzae type b (Hib) in great detail. In this study, we have compared the antibody response to Hib of humans with those of other primates. Studies of isoelectric points and VK subgroup usage show that, like humans, nonhuman primates produce oligoclonal antibodies. Also, monkey antibodies to the Hib polysaccharide are as protective as human antibodies in an in vivo model of Hib infection. Thus, we conclude that nonhuman primates produce antibodies to Hib polysaccharide that are structurally and functionally similar to human antibodies and are a good model for testing human vaccines
Bibliography:L70
9506054
T10
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0019-9567
1098-5522
DOI:10.1128/IAI.62.6.2426-2431.1994